CoChat
Sign Up
Cited by 145

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study

van der Voort, Ella A.M., Koehler, Edith M., Dowlatshahi, Emmilia A., Hofman, Albert, Stricker, Bruno H., Janssen, Harry L.A., Schouten, Jeoffrey N.L., Nijsten, Tamar·2014·Journal of the American Academy of Dermatology
DOI 10.1016/j.jaad.2013.10.044
Open this paper in CoChat — free account

Abstract

Background Recent case-control studies observed an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with psoriasis, which is relevant in selecting optimal psoriasis treatment. Objective We sought to compare the prevalence of NAFLD in people with psoriasis and those without psoriasis. Methods This large prospective population-based cohort study (part of the Rotterdam Study) enrolled elderly participants (>55 years). NAFLD was diagnosed as fatty liver on ultrasonography in the absence of other liver diseases. Participants with psoriasis were identified using a validated algorithm. Multivariable logistic regression model was used to assess whether psoriasis was associated with NAFLD after adjusting for demographic, lifestyle characteristics, and laboratory findings. Results In total, 2292 participants were included (mean age 76.2 ± 6.0 years; 58.7% female; mean body mass index 27.4 ± 4.2kg/m(2)) of whom 118 (5.1%) had psoriasis. The prevalence of NAFLD was 46.2% in patients with psoriasis compared with 33.3% for the reference group without psoriasis (P = .005). Psoriasis was significantly associated with NAFLD; after adjustment for alcohol consumption, pack-years and smoking status, presence of metabolic syndrome, and alanine aminotransferase, psoriasis remained a significant predictor of NAFLD (adjusted odds ratio 1.7, 95% confidence interval 1.1-2.6). Limitations This was a cross-sectional study. Conclusion Elderly participants with psoriasis are 70…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jaad.2013.10.044

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 37

  1. Hamaguchi, 2005, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease, Ann Intern Med, 143, 722, 10.7326/0003-4819-143-10-200511150-00009 · DOI
  2. Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Ann Med, 43, 617, 10.3109/07853890.2010.518623 · DOI
  3. Ioannou, 2006, The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002, Am J Gastroenterol, 101, 76, 10.1111/j.1572-0241.2005.00341.x · DOI
  4. Wenk, 2011, Psoriasis and non-alcoholic fatty liver disease, J Eur Acad Dermatol Venereol, 25, 383, 10.1111/j.1468-3083.2010.03841.x · DOI
  5. Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 · DOI
  6. Adams, 2005, Nonalcoholic fatty liver disease, CMAJ, 172, 899, 10.1503/cmaj.045232 · DOI
  7. Taylor, 2008, Drug use and toxicity in psoriatic disease: focus on methotrexate, J Rheumatol, 35, 1454
  8. Gisondi, 2009, Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis, J Hepatol, 51, 758, 10.1016/j.jhep.2009.04.020 · DOI · Paper page
  9. Madanagobalane, 2012, The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India, Australas J Dermatol, 53, 190, 10.1111/j.1440-0960.2012.00905.x · DOI
  10. Boehncke, 2012, Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting, J Rheumatol, 39, 441, 10.3899/jrheum.111245 · DOI
  11. Davidovici, 2010, Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions, J Invest Dermatol, 130, 1785, 10.1038/jid.2010.103 · DOI
  12. Kimball, 2010, Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis, Am J Med, 123, 350, 10.1016/j.amjmed.2009.08.022 · DOI
  13. Hofman, 2011, The Rotterdam study: 2012 objectives and design update, Eur J Epidemiol, 26, 657, 10.1007/s10654-011-9610-5 · DOI
  14. Dowlatshahi, 2013, Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam study, J Invest Dermatol, 133, 2347, 10.1038/jid.2013.131 · DOI
  15. Langley, 2004, Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment, J Am Acad Dermatol, 51, 563, 10.1016/j.jaad.2004.04.012 · DOI
  16. Hamaguchi, 2007, The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation, Am J Gastroenterol, 102, 2708, 10.1111/j.1572-0241.2007.01526.x · DOI
  17. Grundy, 2005, Diagnosis and management of the metabolic syndrome–an American Heart Association/National Heart, Lung, and Blood Institute scientific statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 · DOI · Paper page
  18. Marchesini, 2005, Nonalcoholic fatty liver disease and the metabolic syndrome, Curr Opin Lipidol, 16, 421, 10.1097/01.mol.0000174153.53683.f2 · DOI
  19. Kotronen, 2008, Fatty liver: a novel component of the metabolic syndrome, Arterioscler Thromb Vasc Biol, 28, 27, 10.1161/ATVBAHA.107.147538 · DOI
  20. Koehler, 2012, Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study, J Hepatol, 57, 1305, 10.1016/j.jhep.2012.07.028 · DOI
  21. Loria, 2007, Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question, Nutr Metab Cardiovasc Dis, 17, 684, 10.1016/j.numecd.2007.01.007 · DOI
  22. Targher, 2008, Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?, Diabetologia, 51, 1947, 10.1007/s00125-008-1135-4 · DOI
  23. Uysal, 1997, Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function, Nature, 389, 610, 10.1038/39335 · DOI · Paper page
  24. Dowlatshahi, 2013, Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis, Br J Dermatol, 169, 266, 10.1111/bjd.12355 · DOI
  25. Nijsten, 2009, Complexity of the association between psoriasis and comorbidities, J Invest Dermatol, 129, 1601, 10.1038/jid.2009.55 · DOI
  26. Li, 2012, Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease, World J Gastroenterol, 18, 6546, 10.3748/wjg.v18.i45.6546 · DOI
  27. Perera, 2012, Psoriasis, Annu Rev Pathol, 7, 385, 10.1146/annurev-pathol-011811-132448 · DOI
  28. Langman, 2001, Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury, J Gastroenterol Hepatol, 16, 1395, 10.1046/j.1440-1746.2001.02644.x · DOI
  29. Rosenberg, 2007, Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment, J Hepatol, 46, 1111, 10.1016/j.jhep.2007.01.024 · DOI · Paper page
  30. Rivera, 2010, Nonalcoholic fatty liver disease and psoriasis, Actas Dermosifiliogr, 101, 657, 10.1016/j.ad.2010.06.004 · DOI
  31. Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 142, 1592, 10.1053/j.gastro.2012.04.001 · DOI
  32. Stern, 2004, Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction, J Investig Dermatol Symp Proc, 9, 136, 10.1046/j.1087-0024.2003.09102.x · DOI
  33. Amarapurkar, 2007, Prevalence of non-alcoholic fatty liver disease: population-based study, Ann Hepatol, 6, 161, 10.1016/S1665-2681(19)31922-2 · DOI
  34. Chen, 2007, Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan, J Gastroenterol Hepatol, 22, 1482, 10.1111/j.1440-1746.2006.04615.x · DOI
  35. Frith, 2009, Non-alcoholic fatty liver disease in older people, Gerontology, 55, 607, 10.1159/000235677 · DOI
  36. Li, 2009, Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China, Hepatobiliary Pancreat Dis Int, 8, 377
  37. Park, 2006, Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults, J Gastroenterol Hepatol, 21, 138, 10.1111/j.1440-1746.2005.04086.x · DOI

Cited by

Sorted by citations

See all 145

Metadata

Authors
van der Voort, E. A. M., Koehler, E. M., Dowlatshahi, E. A., Hofman, A., Stricker, B. H., Janssen, H. L. A., Schouten, J. N. L., & Nijsten, T.
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
2014-03
Volume
70
Issue
3
Pages
517-524
ISSN
0190-9622
DOI
10.1016/j.jaad.2013.10.044
Cited by
145
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. https://app.cochat.ai/papers/10.1016/j.jaad.2013.10.044
The paper
van der Voort, E. A. M., Koehler, E. M., Dowlatshahi, E. A., Hofman, A., Stricker, B. H., Janssen, H. L. A., Schouten, J. N. L., & Nijsten, T. (2014). Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2013.10.044